BT delivered by the Alair™ System, is a safe outpatient procedure for adult patients with severe asthma. The Alair System uses mild heat to reduce the amount of excess airway smooth muscle tissue in the airways. Less muscle tissue means less airway constriction during an asthma attack, allowing patients to breathe more easily.
Alair™ Bronchial Thermoplasty System*
|Order Number||Model Number||Description||Packaging|
|M005ATS20000||Alair ATS 200||Alair Bronchial Thermoplasty Controller||Each|
|M005ATS25010||Alair ATS 2-5||Alair Bronchial Thermoplasty Catheter**||Each|
|M005ATS20110||Alair ATS 201||Alair RF Controller Accessory Kit||Each|
*Service Agreement available with 1, 2, 3, and 4 year terms.
**Note: Initial stocking order requires a minimum order of 6 catheters (covering the complete treatment of 2 patients).
Brief Statement of Relevant Indications for Use, Contraindications, Warnings, and Adverse Events: The Alair™ Bronchial Thermoplasty System is indicated for the treatment of severe persistent asthma in patients 18 years and older whose asthma is not well controlled with inhaled corticosteroids and long-acting beta-agonists. The Alair System is not for use in patients with an active implantable electronic device or known sensitivity to medications used in bronchoscopy. Previously treated airways of the lung should not be retreated with the Alair System. Patients should be stable and suitable to undergo bronchoscopy. The most common side effect of BT is an expected transient increase in the frequency and worsening of respiratory-related symptoms.